Senate Reconciliation Bill Would Reduce the Price of Insulin
Today, Senate Democrats, including Senate Diabetes Caucus Co-Chair Sen. Jeanne Shaheen (D-NH), announced potential updates to the Inflation Reduction Act, which was released earlier this week. The Senate bill could now include a $35 monthly cap on out-of-pocket costs for insulin, and it could also allow Medicare to directly negotiate the price of insulin products with drug manufacturers. The American Diabetes Association® (ADA) has been the leading advocate for insulin copay caps across the country, resulting in the enactment of these out-of-pocket limits in 22 states and the District of Columbia. Additionally, the ADA has been a vocal supporter of Medicare price negotiation for prescription drugs, especially insulin.
“One in every three dollars spent on drugs in the U.S. is spent on someone with diabetes, and we believe strongly that prescription drug reforms in the Inflation Reduction Act should specifically address the rising cost of insulin,” said Lisa Murdock, the ADA’s chief advocacy officer. “The ADA is grateful to Sen. Shaheen for her work to ensure people with diabetes benefit from this historic legislation.”
# # #
About the American Diabetes Association
The American Diabetes Association (ADA) is the nation’s leading voluntary health organization fighting to bend the curve on the diabetes epidemic and help people living with diabetes thrive. For 81 years the ADA has driven discovery and research to treat, manage, and prevent diabetes while working relentlessly for a cure. Through advocacy, program development, and education we aim to improve the quality of life for the over 133 million Americans living with diabetes or prediabetes. Diabetes has brought us together. What we do next will make us Connected for Life. To learn more or to get involved, visit us at diabetes.org or call 1-800-DIABETES (1-800-342-2383). Join the fight with us on Facebook (American Diabetes Association), Spanish Facebook (Asociación Americana de la Diabetes), Twitter (@AmDiabetesAssn) and Instagram (@AmDiabetesAssn).
